Selecting appropriate empirical antibiotic regimens for paediatric bloodstream infections: Application of a Bayesian decision model to local and pooled antimicrobial resistance surveillance data

Journal of Antimicrobial Chemotherapy

Volumn 71, Issue 3, 2016, Pages 794-802

  Bielicki, Julia A ^a,b   Sharland, Mike ^a   Johnson, Alan P ^c   Henderson, Katherine L ^c   Cromwell, David A ^b   Berger, C ^d   Esposito, S ^e   Danieli, E ^e   Tenconi, R ^e   Folgori, L ^f   Bernaschi, P ^f   Santiago, B ^g   Saavedra, J ^g   Cercenado, E ^g   Brett, A ^h   Rodrigues, F ^h   Cizman, M ⁱ   Jazbec, J ⁱ   Babnik, J ⁱ   Pavčnik, Maja ⁱ   Pirs M ^j   Mueller Premrov, M ^j   Lindner, M ^k   Borte, M ^k   Lippmann, N ^l   Schuster, V ^l   Thurmer A ^m   Lander, F ^m   Elias, J ⁿ   Liese, J ⁿ   Durst, A ^o   Weichert, S ^o   Schneider, C ^p   Hufnagel, M ^p   Rack, A ^q   Hubner J ^q   Dubos, F ^r   Lagree, M ^r   Dessein, R ^r   Tissieres, P ^s   Cuzon, G ^s   Gajdos, V ^t   Doucet Populaire, F ^t   Usonis, V ^u   Gurksniene, V ^u   Bernatoniene, G ^u   Tsolia, M ^v   Spyridis, N ^v   Lebessi, E ^w   Doudoulakakis, A ^w   Lutsar, I ^x   Koljalg S ^x   Schulin T ^y   Warris, A ^y   more..

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

^d UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^e FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^f BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^g HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^h CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

ⁱ UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^j UNIVERSITY OF LJUBLJANA   (Slovenia)

^k Klinikum St Georg   (Germany)

^l UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^m UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

ⁿ UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^o UNIVERSITY OF HEIDELBERG   (Germany)

^p UNIVERSITY OF FREIBURG   (Germany)

^q LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^r LILLE UNIVERSITY HOSPITAL   (France)

^s BICÊTRE HOSPITAL   (France)

^t HÔPITAL ANTOINE BÉCLÈRE   (France)

^u VILNIUS UNIVERSITY   (Lithuania)

^v UNIVERSITY OF ATHENS   (Greece)

^w P AND A KYRIAKOU CHILDREN S HOSPITAL   (Greece)

^x UNIVERSITY OF TARTU   (Estonia)

^y RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CEFTRIAXONE; GENTAMICIN; MEROPENEM; PIPERACILLIN; TAZOBACTAM; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; BAYES THEOREM; BLOOD CULTURE; BLOODSTREAM INFECTION; CHILD; CHILDHOOD DISEASE; ENTEROBACTER; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; HUMAN; INFANT; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; NEWBORN; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; WEIGHTED INCIDENCE SYNDROMIC COMBINATION ANTIBIOGRAM; BACTEREMIA; BACTERIUM; DECISION SUPPORT SYSTEM; DRUG EFFECTS; EPIDEMIOLOGICAL MONITORING; FEMALE; INCIDENCE; MALE; MICROBIAL SENSITIVITY TEST; PRESCHOOL CHILD;

ADOLESCENT; ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIA; BAYES THEOREM; CHILD; CHILD, PRESCHOOL; DECISION SUPPORT TECHNIQUES; EPIDEMIOLOGICAL MONITORING; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MICROBIAL SENSITIVITY TESTS;

EID: 84960806286     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkv397     Document Type: Article

References (32)

1. Schlapbach LJ, Straney L, Alexander J et al. Mortality related to invasive infections, sepsis, and septic shock in critically ill children in Australia and New Zealand, 2002-13: a multicentre retrospective cohort study. Lancet Infect Dis 2015; 15: 46-54.
2. Kaukonen KM, Bailey M, Suzuki S et al. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012. JAMA 2014; 311: 1308-16.
3. Paul M, Shani V, Muchtar E et al. Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis. Antimicrob Agents Chemother 2010; 54: 4851-63.
4. MacFadden DR, Leis JA, Mubareka S et al. The opening and closing of empiric windows: the impact of rapid microbiologic diagnostics. Clin Infect Dis 2014; 59: 1199-200.
5. Hindler JF, Stelling J. Analysis and presentation of cumulative antibiograms: a new consensus guideline from the Clinical and Laboratory Standards Institute. Clin Infect Dis 2007; 44: 867-73.
6. Hebert C, Ridgway J, Vekhter B et al. Demonstration of the weightedincidence syndromic combination antibiogram: an empiric prescribing decision aid. Infect Control Hosp Epidemiol 2012; 33: 381-8.
7. Davis ME, Anderson DJ, Sharpe M, et al. Constructing unit-specific empiric treatment guidelines for catheter-related and primary bacteremia by determining the likelihood of inadequate therapy. Infect Control Hosp Epidemiol 2012; 33: 416-20.
8. Muller-Pebody B, Johnson AP, Heath PTet al. Empirical treatment of neonatal sepsis: are the current guidelines adequate? Arch Dis Child Fetal Neonatal Ed 2011; 96: F4-8.
9. Randhawa V, Sarwar S, Walker S et al. Weighted-incidence syndromic combination antibiograms to guide empiric treatment of critical care infections: a retrospective cohort study. Crit Care 2014; 18: R112.
10. Blondeau JM, Tillotson GS. Formula to help select rational antimicrobial therapy (FRAT): its application to community-and hospital-acquired urinary tract infections. Int J Antimicrob Agents 1999; 12: 145-50.
11. Bielicki JA, Lundin R, Sharland M et al. Antibiotic resistance prevalence in routine bloodstream isolates from children's hospitals varies substantially from adult surveillance data in Europe. Pediatr Infect Dis J 2015; 34: 734-41.
12. Briggs A, Claxton K, Sculpher M. Decision Modelling for Health Economic Evaluation. Oxford: Oxford University Press, 2006.
13. Gelman A, Carlin JB, Stern HS et al. Bayesian Data Analysis. Boca Raton: Chapman & Hall, 2013.
14. Versporten A, Sharland M, Bielicki J et al. The Antibiotic Resistance and Prescribing in European Children project: a neonatal and pediatric antimicrobial web-based point prevalence survey in 73 hospitals worldwide. Pediatr Infect Dis J 2013; 32: e242-53.
15. Isaacs D. A ten year, multicentre study of coagulase negative staphylococcal infections in Australasian neonatal units. Arch Dis Child Fetal Neonatal Ed 2003; 88: F89-93.
16. Wells R, Le Doare K, Sharland M et al. Targeted empiric antibiotic therapy for children with non-oncological comorbidities and community-onset invasive bacterial infections. J Infect 2015; 71: 294-301.
17. EUCAST. Clinical Breakpoints. http://www.eucast.org/clinical_breakpoints/.
18. Leclercq R, Cantón R, Brown DFJ et al. EUCASTexpert rules in antimicrobial susceptibility testing. Clin Microbiol Infect 2013; 19: 141-60.
19. BSAC. BSAC Bacteraemia Resistance Surveillance Programme. http://www.bsacsurv.org/reports/bacteraemia/.
20. Spiegelhalter DJ. Funnel plots for comparing institutional performance. Stat Med 2005; 24: 1185-202.
21. Kuster SP, Ruef C, Zbinden R et al. Stratification of cumulative antibiograms in hospitals for hospital unit, specimen type, isolate sequence and duration of hospital stay. J Antimicrob Chemother 2008; 62: 1451-61.
22. Dellinger RP, Levy MM, Rhodes A et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013; 41: 580-637.
23. Lalani T, Varkey JB, Drew R et al. Analysis of two-and three-year trends in antimicrobial resistance in intensive care units using unit-specific antibiograms. Scand J Infect Dis 2008; 40: 672-4.
24. Spiegelhalter DJ, Abrams KR, Myles JP. Bayesian Approaches to Clinical Trials and Health-Care Evaluation. Chichester: Wiley, 2004.
25. Paediatric Formulary Committee. British National Formulary for Children 2014-2015. London: BMJ Group, Royal Pharmaceutical Press and RCPCH Publications, 2014.
26. Schmiemann G, Gagyor I, Hummers-Pradier E et al. Resistance profiles of urinary tract infections in general practice-an observational study. BMC Urol 2012; 12: 33.
27. BSAC. The BSAC Resistance Surveillance Project. http://www.bsacsurv.org.
28. Wilson J, Elgohari S, Livermore DM et al. Trends among pathogens reported as causing bacteraemia in England, 2004-2008. Clin Microbiol Infect 2011; 17: 451-8.
29. Laupland KB, Gregson DB, Flemons WW et al. Burden of communityonset bloodstream infection: a population-based assessment. Epidemiol Infect 2007; 135: 1037-42.
30. Jones RN, Biedenbach DJ, Beach ML. Influence of patient age on the susceptibility patterns of Streptococcus pneumoniae isolates in North America (2000-2001): report from the SENTRY Antimicrobial Surveillance Program. Diagn Micrbiol Infect Dis 2003; 46: 77-80.
31. Boggan JC, Navar-Boggan AM, Jhaveri R. Pediatric-specific antimicrobial susceptibility data and empiric antibiotic selection. Pediatrics 2012; 130: e615-22.
32. Biedenbach DJ, Moet GJ, Jones RN. Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997-2002). Diagn Micrbiol Infect Dis 2004; 50: 59-69.